Update
$Capricor Therapeutics(CAPR.US$ Capricor Therapeutics Announces Upcoming Type-B Meeting with the FDA to Discuss Commercial Manufacturing Planning with an Aim to Expedite BLA Pathway for CAP-1002 in Duchenne Muscular Dystrophy
4 MINUTES AGO, 8:30 AM EST
VIA GLOBENEWSWIRE
4 MINUTES AGO, 8:30 AM EST
VIA GLOBENEWSWIRE
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
